Difference between revisions of "Corona Vaccins First Dose Efficacy"
From Tech
Jump to navigationJump to search (Created page with "=Pfizer= File:Screenshot_2021-07-11_at_11-28-03_Safety_and_Efficacy_of_the_BNT162b2_mRNA_Covid-19_Vaccine_NEJM.png|frame|Efficacy of BNT162b2 (Pfizer) against Covid-19 after...") |
|||
| Line 1: | Line 1: | ||
=Pfizer= |
=Pfizer= |
||
| − | + | [https://www.nejm.org/doi/full/10.1056/nejmoa2034577 Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine] |
|
| + | [[File:Screenshot_2021-07-11_at_11-28-03_Safety_and_Efficacy_of_the_BNT162b2_mRNA_Covid-19_Vaccine_NEJM.png|frame|Efficacy of BNT162b2 (Pfizer) against Covid-19 after the First Dose.]] |
||
| + | |||
| + | =Moderna= |
||
| + | [https://www.fda.gov/media/144434/download#page=28 Vaccines and Related Biological Products Advisory Committee MeetingDecember 17, 2020] |
||
| + | [[File:Screenshot_2021-07-11_at_11-43-02_Vaccines_and_Related_Biological_Products_Advisory_Committee_December_17,_2020_Meeting_Bri-...-.png|frame|Cumulative Incidence Curves for the First COVID-19 Occurrence After Randomization, mITT Set] |
||
Revision as of 10:46, 11 July 2021
Pfizer
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
Efficacy of BNT162b2 (Pfizer) against Covid-19 after the First Dose.
Moderna
Vaccines and Related Biological Products Advisory Committee MeetingDecember 17, 2020 [[File:Screenshot_2021-07-11_at_11-43-02_Vaccines_and_Related_Biological_Products_Advisory_Committee_December_17,_2020_Meeting_Bri-...-.png|frame|Cumulative Incidence Curves for the First COVID-19 Occurrence After Randomization, mITT Set]
